Showing results (41-50 of 57) with videos related to
Sort By:
Pageof 6
Frontiers in Nutrition|December 12, 2022
Gamma-glutamyl-leucine levels are causally associated with elevated cardio-metabolic risksQiong Wu, Jiankang Li, Jinghan Zhu, et al.Cellular and Molecular Life Sciences : CMLS|November 29, 2024
Downregulated KLF4, induced by m6A modification, aggravates intestinal barrier dysfunction in inflammatory bowel diseaseXingchao Zhu, Jiayu Wang, Huan Zhang, et al.Life Sciences|July 18, 2024
BUB1 potentiates gastric cancer proliferation and metastasis by activating TRAF6/NF-κB/FGF18 through m6A modificationKun Wang, Kanger Shen, Jiayu Wang, et al.Journal of Cellular and Molecular Medicine|February 9, 2024
ITGBL1 promotes anoikis resistance and metastasis in human gastric cancer via the AKT/FBLN2 axisKanger Shen, Wei Xia, Kun Wang, et al.Scientific Reports|July 24, 2015
One Dimensional Graphitic Carbon Nitrides as Effective Metal-Free Oxygen Reduction CatalystsMuhammad Tahir, Nasir Mahmood, Jinghan Zhu, et al.Advanced Materials (Deerfield Beach, Fla.)|January 17, 2020
Light-Responsive Colloidal Crystals Engineered with DNAJinghan Zhu, Haixin Lin, Youngeun Kim, et al.Cancer Letters|October 2, 2023
Targeting LINC01607 sensitizes hepatocellular carcinoma to Lenvatinib via suppressing mitophagyYuxin Zhang, Yujie Zhang, Haisu Tao, et al.Small (Weinheim an Der Bergstrasse, Germany)|April 29, 2015
Nitrogen-Doped Carbon Nanotube Aerogels for High-Performance ORR CatalystsRan Du, Na Zhang, Jinghan Zhu, et al.Cancer Communications (London, England)|May 30, 2025
Simvastatin overcomes the pPCK1-pLDHA-SPRINGlac axis-mediated ferroptosis and chemo-immunotherapy resistance in AKT-hyperactivated intrahepatic cholangiocarcinomaJinghan Zhu, Yixiao Xiong, Yuxin Zhang, et al.BMC Cancer|February 11, 2023
Association between diverticular disease and colorectal cancer: a bidirectional mendelian randomization studyYanxi Zhang, Han Zhang, Jinghan Zhu, et al.Pageof 6